Hosted on MSN8h
EU’s Clinical Trials Regulation comes into full force
The ruling requires all trials across the EU to be filed through the European Medicines Agency’s digital filing system.
GH Research Shares Rise Ahead of Release of Clinical-Trial Results
Shares of GH Research climbed after the company said it would provide data from a trial of its drug for treatment-resistant depression. The stock rose 5.2%, to $11.15, in after-hours trading on Friday ...
Zacks.com on MSN15h
Merck Halts Second PAH Drug Study Early on Strong Efficacy Results
Merck MRK has decided to stop the phase III HYPERION study early. The study evaluates MRK’s pulmonary arterial hypertension ...
cirm.ca.gov16h
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...
Compass Therapeutics Stock Skyrockets 108% in a Month: Here's Why
CMPX stock more than doubles following updates regarding the pipeline development programs and current cash position by the company.
FDA approves new type of nonopioid painkiller for acute pain
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Healio23h
‘Call to action’: Head and neck cancer trials in US becoming less diverse
Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past decade, according to retrospective ...